Research map: Serum Copeptin Rises After Tolvaptan for Hyponatraemia, but Does Not Predict Risk of Rapid Sodium Rise: Pre‐Specified Secondary Analysis of the TVFR Trial

Back to the article

Papers in this map

  1. Fitting Linear Mixed-Effects Models Using lme4 · Douglas M. Bates · 2015 · 89318 citations · Cited by this paper
  2. Long‐Term Outcomes of Gonadotropin‐Releasing Hormone Analogue Therapy in Central Precocious Puberty: A Comparative Analysis of Obese and Normal‐Weight Girls · 2026 · Related
  3. Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations · Joseph George Verbalis · 2013 · 1213 citations · Cited by this paper
  4. Clinical Challenges in Transition to Adult Care for Young People With Endocrinopathies · 2026 · Related
  5. Clinical practice guideline on diagnosis and treatment of hyponatraemia · Goce B. Spasovski · 2014 · 856 citations · Cited by this paper
  6. Supraphysiological Glucocorticoid Doses and Pitfalls of Annual Biomarker Monitoring in Adults With CAH · 2026 · Related
  7. Visualizing Fit and Lack of Fit in Complex Regression Models with Predictor Effect Plots and Partial Residuals · John Fox · 2018 · 604 citations · Cited by this paper
  8. Revisiting Pre‐RAI MLR, PNI, and NRI Estimating Early and Higher Recurrence in Intermediate‐Risk DTC in Thyroidology · 2026 · Related
  9. Copeptin in the Differential Diagnosis of Hyponatremia · Wiebke Kristin Fenske · 2008 · 208 citations · Cited by this paper
  10. Maternal–Neonatal Metabolic Continuity and Early Postnatal HPG Axis Activity in Healthy Term Neonates · 2026 · Related
  11. Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management · Annabelle M Warren · 2023 · 135 citations · Cited by this paper
  12. Identifying Failure Predictors in Thyroid Nodule Radiofrequency Ablation Using Multivariate Analysis: A Single‐Centre Experience · 2026 · Related
  13. A Copeptin-Based Classification of the Osmoregulatory Defects in the Syndrome of Inappropriate Antidiuresis · Wiebke Kristin Fenske · 2014 · 86 citations · Cited by this paper
  14. Comparative Analysis of Incidental and Non‐Incidental Papillary Thyroid Microcarcinoma Outcomes: Implications on Management Recommendations · 2026 · Related
  15. Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease · Ron T. Gansevoort · 2019 · 80 citations · Cited by this paper
  16. Optimizing Parathyroid Localization in Real Life: The Role of Expert‐Performed Ultrasonography · 2026 · Related
  17. Evaluation of copeptin and commonly used laboratory parameters for the differential diagnosis of profound hyponatraemia in hospitalized patients: ‘The Co-MED Study' · N Nigro · 2016 · 78 citations · Cited by this paper
  18. Flushing: Neuroendocrine Mechanisms and a Structured Diagnostic Approach · 2026 · Related
  19. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan · Jesse H. Morris · 2018 · 58 citations · Cited by this paper
  20. Approach to the Patient: “Utility of the Copeptin Assay” · Mirjam Christ‐Crain · 2022 · 53 citations · Cited by this paper
  21. Ontogeny of bovine neurohypophysial hormone precursors · Brigitte Lévy · 1986 · 30 citations · Cited by this paper
  22. Association between copeptin levels and treatment responses to hypertonic saline infusion in patients with symptomatic hyponatremia: a prospective cohort study · Suryeong Go · 2021 · 18 citations · Cited by this paper
  23. Tolvaptan vs. Furosemide-Based Diuretic Regimens in Patients Hospitalized for Heart Failure with Hyponatremia (AQUA-AHF) · Tien M. H. Ng · 2020 · 17 citations · Cited by this paper
  24. Risk factors for sodium overcorrection in non-hypovolemic hyponatremia patients treated with tolvaptan · Yukyung Kim · 2020 · 15 citations · Cited by this paper
  25. Low-Dose Tolvaptan for the Treatment of Syndrome of Inappropriate Antidiuretic Hormone–Associated Hyponatremia: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Clinical Effectiveness and Safety · David Lewellyn · 2025 · 13 citations · Cited by this paper
  26. Urea-stimulated copeptin: a novel diagnostic approach in polyuria polydipsia syndrome · Sven Lustenberger · 2025 · 12 citations · Cited by this paper
  27. Copeptin is not useful as a marker of malignant disease in the syndrome of inappropriate antidiuresis · Bettina Felicitas Winzeler · 2020 · 11 citations · Cited by this paper
  28. Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trial · Annabelle M Warren · 2022 · 10 citations · Cited by this paper
  29. Apelin and Copeptin Levels in Patients With Chronic SIAD Treated With Empagliflozin · Sophie Monnerat · 2024 · 6 citations · Cited by this paper
  30. Tolvaptan vs Fluid Restriction in Moderate-Profound Hyponatremia: An Open-Label Randomized Clinical Trial · Annabelle M Warren · 2025 · 3 citations · Cited by this paper
  31. Diagnostic algorithm of hyponatremia · Rose Lin · 2025 · 3 citations · Cited by this paper
  32. Efficacy of Low-Dose Tolvaptan for Treatment of Profound Hyponatremia in Syndrome of Inappropriate Antidiuresis (SIAD): The EFFLUX-FLUID TRIAL · Narongchai Jaiyen · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)